Internship: Patient Safety and Pharmacovigilance jobs in United States
cer-icon
Apply on Employer Site
company-logo

Kailera Therapeutics · 21 hours ago

Internship: Patient Safety and Pharmacovigilance

positionWaltham, Massachusetts
timeInternship
remoteHybrid
seniorityIntern
money$25/hr - $30/hr

Kailera is committed to developing therapies that enhance health and well-being. They are seeking a Patient Safety and Pharmacovigilance Intern who will assist the PSPV team with various tasks and support key projects related to safety data analysis and vendor management.

BiotechnologyPharmaceuticalTherapeutics

Responsibilities

Research and understand the disease, symptoms, and treatment under investigation
Participate in safety data analysis/signal detection (ICSR and aggregate data review)
Understand the process of vendor management
Review applicable Health Authority regulations and ICH guidelines to develop working knowledge of PSPV reporting obligations to ensure patient safety
Lead a defined project (e.g. process optimization, data visualization, or data analytics) and prepare a final presentation for department and company leadership
Opportunity to support PSPV projects

Qualification

Drug safetyPharmacovigilanceData analysisCommunication skillsTeamwork

Required

Proactive, engaged, eager and willing to learn approach to work
Support and be part of the Kailera core values: Courageous, Collaborative, Compassionate, and Committed
Excellent oral and written communication skills
Interest and/or experience in drug safety and pharmacovigilance a plus
Ability to work well in a fast-paced team environment
Bachelor's degree candidates who have completed two or more years and are pursuing a degree in life sciences (nursing, neuroscience, psychology, psychiatry, biology, pharmacy)

Benefits

Comprehensive health coverage
Monthly wellness stipend
Flexible time off
Paid holidays
Year-end shutdown
Generous 401(k) match
Tuition reimbursement
Commuter benefits
Disability and life insurance
Annual bonus opportunities
Equity grants

Company

Kailera Therapeutics

twittertwittertwitter
company-logo
Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
dateFounded in 2024
location
Waltham, Massachusetts, USA
people-size51-200 employees
web-link
https://www.kailera.com

Funding

Current Stage
Growth Stage
Total Funding
$1B
Key Investors
Bain Capital Private Equity
2025-10-14Series B· $600M
2024-10-01Series A· $400M

Leadership Team

leader-logo
Ronald Renaud
President & CEO
linkedin
leader-logo
Paul Burgess
Chief Operating Officer and Chief Business Officer
linkedin

Recent News

Boston Globe
Mass. startups raised more VC money last year, but those in other states did much better
2026-01-16
GlobeNewswire
Kailera Therapeutics Announces First Participants Randomized in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide (KAI-9531)
2026-01-13
GlobeNewswire
Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer
2026-01-05
Company data provided by crunchbase